User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.

  • Open access
  • PDF
  • 1.63 M
  1. Neirynck Sabine, Deroo Tom, Saelens Xavier, Vanlandschoot Peter, Jou Willy Min, Fiers Walter, A universal influenza A vaccine based on the extracellular domain of the M2 protein, 10.1038/13484
  2. El Bakkouri K., Descamps F., De Filette M., Smet A., Festjens E., Birkett A., Van Rooijen N., Verbeek S., Fiers W., Saelens X., Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection, 10.4049/jimmunol.0902147
  3. J Virol, 64, 1375 (1990)
  4. Lamb Robert A., Zebedee Suzanne L., Richardson Christopher D., Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface, 10.1016/0092-8674(85)90211-9
  5. J Virol, 62, 2762 (1988)
  6. Feng JingQi, Zhang Manxin, Mozdzanowska Krystyna, Zharikova Darya, Hoff Henry, Wunner William, Couch Robert B, Gerhard Walter, 10.1186/1743-422x-3-102
  7. Zhong Weimin, Reed Carrie, Blair Patrick J., Katz Jacqueline M., Hancock Kathy, Aranio Darbi, Bai Yaohui, Browning Peter, Branch Alicia, Steward-Clark Evelene, Cronin Li, Dababneh Hanan, Gillis Eric, Holiday Crystal, Liu Feng, Lu Xiuhua, Tatum Heather R., Quinn Conrad, Soroka Stephen, Schiffer Jarad, Sun Hong, Thomas Leilani, Tsang Byron, Veguilla Vic, Wang David, Whaley Melissa, , Serum Antibody Response to Matrix Protein 2 Following Natural Infection With 2009 Pandemic Influenza A(H1N1) Virus in Humans, 10.1093/infdis/jit811
  8. De Filette Marina, Martens Wouter, Roose Kenny, Deroo Tom, Vervalle Frederik, Bentahir Mostafa, Vandekerckhove Joel, Fiers Walter, Saelens Xavier, An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2, 10.1074/jbc.m800650200
  9. Fan Jiang, Liang Xiaoping, Horton Melanie S, Perry Helen C, Citron Michael P, Heidecker Gwen J, Fu Tong-Ming, Joyce Joseph, Przysiecki Craig T, Keller Paul M, Garsky Victor M, Ionescu Roxana, Rippeon Yvette, Shi Li, Chastain Michael A, Condra Jon H, Davies Mary-Ellen, Liao Jason, Emini Emilio A, Shiver John W, Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys, 10.1016/j.vaccine.2004.02.021
  10. Jegerlehner A., Schmitz N., Storni T., Bachmann M. F., Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity, 10.4049/jimmunol.172.9.5598
  11. Schotsaert Michael, De Filette Marina, Fiers Walter, Saelens Xavier, Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments, 10.1586/erv.09.6
  12. Wang Bao-Zhong, Gill Harvinder S., Kang Sang-Moo, Wang Li, Wang Ying-Chun, Vassilieva Elena V., Compans Richard W., Enhanced Influenza Virus-Like Particle Vaccines Containing the Extracellular Domain of Matrix Protein 2 and a Toll-Like Receptor Ligand, 10.1128/cvi.00153-12
  13. Turley Christine B., Rupp Richard E., Johnson Casey, Taylor David N., Wolfson Julie, Tussey Lynda, Kavita Uma, Stanberry Lawrence, Shaw Alan, Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults, 10.1016/j.vaccine.2011.05.041
  14. WANG R, SONG A, LEVIN J, DENNIS D, ZHANG N, YOSHIDA H, KORIAZOVA L, MADURA L, SHAPIRO L, MATSUMOTO A, Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein, 10.1016/j.antiviral.2008.06.002
  15. Schmitz Nicole, Beerli Roger R., Bauer Monika, Jegerlehner Andrea, Dietmeier Klaus, Maudrich Melanie, Pumpens Paul, Saudan Philippe, Bachmann Martin F., Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection : Immunity to infection, 10.1002/eji.201041225
  16. DiLillo David J, Tan Gene S, Palese Peter, Ravetch Jeffrey V, Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo, 10.1038/nm.3443
  17. Cho Ki Joon, Schepens Bert, Seok Jong Hyeon, Kim Sella, Roose Kenny, Lee Ji-Hye, Gallardo Rodrigo, Van Hamme Evelien, Schymkowitz Joost, Rousseau Frederic, Fiers Walter, Saelens Xavier, Kim Kyung Hyun, Structure of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus in Complex with a Protective Monoclonal Antibody, 10.1128/jvi.02576-14
  18. Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P, Structural Analysis of Human IgG-Fc Glycoforms Reveals a Correlation Between Glycosylation and Structural Integrity, 10.1016/s0022-2836(02)01250-0
  19. Jefferis Roy, Lund John, Pound John D., IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation, 10.1111/j.1600-065x.1998.tb01188.x
  20. Forthal D. N., Gach J. S., Landucci G., Jez J., Strasser R., Kunert R., Steinkellner H., Fc-Glycosylation Influences Fc  Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12, 10.4049/jimmunol.1002600
  21. Herter S., Birk M. C., Klein C., Gerdes C., Umana P., Bacac M., Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity, 10.4049/jimmunol.1301249
  22. Shields Robert L., Lai Jadine, Keck Rodney, O'Connell Lori Y., Hong Kyu, Meng Y. Gloria, Weikert Stefanie H. A., Presta Leonard G., Lack of Fucose on Human IgG1N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity, 10.1074/jbc.m202069200
  23. Shinkawa Toyohide, Nakamura Kazuyasu, Yamane Naoko, Shoji-Hosaka Emi, Kanda Yutaka, Sakurada Mikiko, Uchida Kazuhisa, Anazawa Hideharu, Satoh Mitsuo, Yamasaki Motoo, Hanai Nobuo, Shitara Kenya, The Absence of Fucose but Not the Presence of Galactose or BisectingN-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity, 10.1074/jbc.m210665200
  24. Corrales-Aguilar Eugenia, Trilling Mirko, Hunold Katja, Fiedler Manuela, Le Vu Thuy Khanh, Reinhard Henrike, Ehrhardt Katrin, Mercé-Maldonado Eva, Aliyev Enver, Zimmermann Albert, Johnson David C., Hengel Hartmut, Human Cytomegalovirus Fcγ Binding Proteins gp34 and gp68 Antagonize Fcγ Receptors I, II and III, 10.1371/journal.ppat.1004131
  25. Corrales-Aguilar Eugenia, Trilling Mirko, Reinhard Henrike, Mercé-Maldonado Eva, Widera Marek, Schaal Heiner, Zimmermann Albert, Mandelboim Ofer, Hengel Hartmut, A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors, 10.1016/j.jim.2012.09.006
  26. Nimmerjahn Falk, Bruhns Pierre, Horiuchi Ken, Ravetch Jeffrey V., FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity, 10.1016/j.immuni.2005.05.010
  27. Guilliams Martin, Bruhns Pierre, Saeys Yvan, Hammad Hamida, Lambrecht Bart N., The function of Fcγ receptors in dendritic cells and macrophages, 10.1038/nri3582
  28. Bruhns P., Properties of mouse and human IgG receptors and their contribution to disease models, 10.1182/blood-2012-01-380121
  29. Nimmerjahn Falk, Ravetch Jeffrey V., FcγRs in Health and Disease, Current Topics in Microbiology and Immunology (2010) ISBN:9783642195440 p.105-125, 10.1007/82_2010_86
  30. Ibañez Lorena Itatí, Roose Kenny, De Filette Marina, Schotsaert Michael, De Sloovere Jessica, Roels Stefan, Pollard Charlotte, Schepens Bert, Grooten Johan, Fiers Walter, Saelens Xavier, M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A, 10.1371/journal.pone.0059081
  31. Song J.-M., Van Rooijen N., Bozja J., Compans R. W., Kang S.-M., Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus, 10.1073/pnas.1012199108
  32. Nimmerjahn F., Lux A., Albert H., Woigk M., Lehmann C., Dudziak D., Smith P., Ravetch J. V., Fc RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo, 10.1073/pnas.1014515107
  33. Lee Suki M. Y., Gardy Jennifer L., Cheung C. Y., Cheung Timothy K. W., Hui Kenrie P. Y., Ip Nancy Y., Guan Y., Hancock Robert E. W., Peiris J. S. Malik, Systems-Level Comparison of Host-Responses Elicited by Avian H5N1 and Seasonal H1N1 Influenza Viruses in Primary Human Macrophages, 10.1371/journal.pone.0008072
  34. Mancardi David A., Iannascoli Bruno, Hoos Sylviane, England Patrick, Daëron Marc, Bruhns Pierre, FcγRIV is a mouse IgE receptor that resembles macrophage FcεRI in humans and promotes IgE-induced lung inflammation, 10.1172/jci36452
  35. Coffman Robert L., Sher Alan, Seder Robert A., Vaccine Adjuvants: Putting Innate Immunity to Work, 10.1016/j.immuni.2010.10.002
  36. Huber V. C., Lynch J. M., Bucher D. J., Le J., Metzger D. W., Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections, 10.4049/jimmunol.166.12.7381
  37. DiLillo David J., Palese Peter, Wilson Patrick C., Ravetch Jeffrey V., Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection, 10.1172/jci84428
  38. Laroy Wouter, Contreras Roland, Callewaert Nico, Glycome mapping on DNA sequencing equipment, 10.1038/nprot.2006.60
Bibliographic reference Van den Hoecke, Silvie ; Ehrhardt, Katrin ; Kolpe, Annasaheb ; El Bakkouri, Karim ; Deng, Lei ; et. al. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.. In: Journal of Virology, Vol. 91, no.7, p. e02500-16 [1-13] (2017)
Permanent URL http://hdl.handle.net/2078.1/206651